by Anna Kamocsai | Oct 21, 2024 | Clinical Research
The U.S. Food and Drug Administration’s (FDA) draft guidance on Diversity Action Plans (DAPs) is a significant step towards addressing the underrepresentation of diverse populations in clinical research. Released in June 2024, this guidance aligns with broader efforts... 
by Anna Kamocsai | Apr 26, 2024 | Clinical Research
The Functional Service Provider (FSP) models in clinical research are becoming increasingly appealing to the pharmaceutical and biotechnology sectors, offering flexible and scalable solutions to outsource specific functions . Currently pharmaceutical and... 
by Nick | Oct 24, 2023 | Clinical Research
The cornerstone of clinical research is its capacity to yield applicable and beneficial results to the entire population. The integrity of this research is fundamentally linked to how well the data encompasses the diverse genetic, physiological, and environmental... 
by Nick | Sep 25, 2023 | Clinical Research
Adaptive clinical trials, with their promise of flexibility and efficiency, have captured the attention of the pharmaceutical world. This innovative approach to clinical research, which allows for modifications during the trial’s progression, has emerged as a... 
by Nick | Aug 17, 2023 | Clinical Research
In early-phase oncology clinical trials, the importance selecting the appropriate clinical endpoints cannot be overstated. These endpoints not only delineate the study’s outcomes but also critically influence the subsequent phases of drug development and the... 
by Nick | Jul 6, 2023 | Clinical Research
The clinical research market is an intricate landscape brimming with diverse players – from prominent global organizations to local and boutique Contract Research Organizations (CROs). These companies play a vital role in assisting pharmaceutical and biotech... 
